...
首页> 外文期刊>The Journal of law, medicine & ethics: a journal of the American Society of Law, Medicine & Ethics >Introduction: The challenge of developing oversight approaches to nanobiotechnology.
【24h】

Introduction: The challenge of developing oversight approaches to nanobiotechnology.

机译:简介:发展对纳米生物技术的监督方法的挑战。

获取原文
获取原文并翻译 | 示例
           

摘要

Nanotechnology is being hailed by many as the "next industrial revolution."A convergence of scientific fields including chemistry, biology, physics, optics, and mechanics, nanoscale science and technology operates at the scale of 1-100 nanometers where structures, devices, and systems have novel functions and properties because of their size. One area with tremendous promise for health and medical applications -"nanobiotechnology"-specifically refers to nanotechnology designed for use in biological systems, in which nanomaterials are derived from biological molecules, or in which nanomaterials mimic biological systems. This convergence of nanotechnology and biology has been envisioned from the inception of the National Nanotechnology Initiative (NNI) at the beginning of this decade.
机译:纳米技术被许多人誉为“下一次工业革命”。包括化学,生物学,物理学,光学和力学在内的科学领域的融合,纳米级科学技术的规模为1-100纳米,其中结构,装置和系统由于大小而具有新颖的功能和特性。在健康和医疗应用方面具有巨大前景的一个领域-“纳米生物技术”-特别是指设计用于生物系统的纳米技术,其中纳米材料源自生物分子,或者其中纳米材料模仿生物系统。从本世纪初的国家纳米技术计划(NNI)成立以来,就已经设想到纳米技术和生物学的融合。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号